UBS’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$480M Buy
7,358,569
+777,282
+12% +$51.3M 0.35% 44
2014
Q2
$449M Buy
6,581,287
+169,814
+3% +$11.4M 0.35% 44
2014
Q1
$416M Buy
6,411,473
+586,417
+10% +$37M 0.37% 43
2013
Q4
$380M Buy
5,825,056
+275,942
+5% +$17.7M 0.36% 42
2013
Q3
$329M Buy
5,549,114
+508,136
+10% +$30.1M 0.34% 49
2013
Q2
$289M Buy
+5,040,978
New +$299M 0.34% 47

Other funds holding CL

UBS's CL Position: Q3 2014 in Review

UBS increased its Colgate-Palmolive (CL) stake by 12% in Q3 2014, buying an estimated $51.3M and bringing the position to 7,358,569 shares worth $480M. The position accounts for 0.35% of the portfolio, ranked #44.

UBS first reported a position in CL in Q2 2013 and has held it in 6 quarters since. 1,191 funds tracked by Wall St. Rank hold CL as of Q3 2014.

  • UBS held 7,358,569 shares of Colgate-Palmolive worth $480M as of Q3 2014.
  • UBS bought 777,282 Colgate-Palmolive shares in Q3 2014, an estimated $51.3M.
  • Colgate-Palmolive made up 0.35% of UBS's portfolio in Q3 2014, its #44 holding.
  • UBS first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 6 quarters since.
  • 1,191 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.